טוען...
Gene therapy for Primary Immunodeficiencies: looking ahead, towards gene correction
Allogeneic hematopoietic stem cell transplantation is the treatment of choice for severe primary immunodeficiencies (PIDs). For patients lacking an HLA-identical donor, gene therapy is an attractive therapeutic option. Approaches based on insertion of a functional gene using viral vectors have provi...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3105180/ https://ncbi.nlm.nih.gov/pubmed/21440291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2011.02.027 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|